| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $88M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Over the last 12 months, insiders at Ocugen, Inc. have bought $0 and sold $0 worth of Ocugen, Inc. stock.
On average, over the past 5 years, insiders at Ocugen, Inc. have bought $65,971 and sold $14.5M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $9,095 was made by Fernandes Prabhavathi (director) on 2024‑11‑26.
| 2024-11-26 | Fernandes Prabhavathi | director | 10,000 0.0034% | $0.91 | $9,095 | +2.20% | ||
| 2024-11-22 | Castillo Kirsten | director | 25,000 0.0086% | $0.91 | $22,848 | +1.63% | ||
| 2023-06-14 | Zhang Junge | director | 200,278 0.0886% | $0.50 | $99,999 | +10.13% | ||
| 2023-02-16 | Sale | Musunuri Shankar | Chief Executive Officer | 100,000 0.046% | $1.08 | $108,000 | -49.04% | |
| 2023-01-17 | Sale | Musunuri Shankar | Chief Executive Officer | 100,000 0.045% | $1.28 | $128,000 | -56.90% | |
| 2022-12-16 | Sale | Musunuri Shankar | Chief Executive Officer | 95,809 0.0407% | $1.43 | $137,007 | -62.55% | |
| 2022-10-14 | Sale | Musunuri Shankar | Chief Executive Officer | 100,000 0.0484% | $1.66 | $166,000 | -49.62% | |
| 2022-10-06 | Sale | Kumar Ramesh | director | 4,500 0.0021% | $1.83 | $8,235 | -54.33% | |
| 2022-08-11 | Sale | Castillo Kirsten | 42,000 0.0211% | $2.91 | $122,220 | -58.58% | ||
| 2022-07-18 | Sale | Kumar Ramesh | 7,500 0.0036% | $2.57 | $19,275 | -49.19% | ||
| 2022-07-14 | Sale | Musunuri Shankar | Chief Executive Officer | 150,000 0.0716% | $2.72 | $408,000 | -52.09% | |
| 2022-05-13 | Sale | Musunuri Shankar | Chief Executive Officer | 125,000 0.0529% | $1.92 | $240,000 | -23.33% | |
| 2022-04-18 | Sale | Kumar Ramesh | 7,500 0.0038% | $2.83 | $21,225 | -33.85% | ||
| 2022-03-16 | Sale | Musunuri Shankar | Chief Executive Officer | 81,823 0.0367% | $2.65 | $216,831 | -31.01% | |
| 2022-02-14 | Sale | Musunuri Shankar | Chief Executive Officer | 90,000 0.045% | $3.74 | $336,600 | -39.01% | |
| 2022-01-18 | Sale | Kumar Ramesh | director | 7,500 0.0037% | $4.07 | $30,525 | -41.25% | |
| 2021-12-16 | Sale | Musunuri Shankar | Chief Executive Officer | 115,000 0.0613% | $5.22 | $600,300 | -50.70% | |
| 2021-11-16 | Sale | Musunuri Shankar | Chief Executive Officer | 115,000 0.0583% | $8.04 | $924,600 | -67.77% | |
| 2021-11-03 | Sale | Zhang Junge | director | 150,300 0.1049% | $17.32 | $2.6M | -79.03% | |
| 2021-11-02 | Sale | Zhang Junge | director | 149,700 0.0772% | $15.75 | $2.36M | -82.93% |
| Lewis Michael | 3610570 1.1011% | $8.41M | 2 | 1 | ||
| Wilmslow Estates Ltd | 10 percent owner | 3610570 1.1011% | $8.41M | 2 | 1 | |
| Musunuri Shankar | Chief Executive Officer | 2190073 0.6679% | $5.1M | 2 | 16 | <0.0001% |
| Sofinnova Venture Partners VIII, L.P. | 10 percent owner | 2085848 0.6361% | $4.86M | 1 | 1 | |
| KIRK RANDAL J | 10 percent owner | 1692366 0.5161% | $3.94M | 0 | 3 | |
| SPLIT ROCK PARTNERS II, LP | 10 percent owner | 1661495 0.5067% | $3.87M | 2 | 1 | <0.0001% |
| Zhang Junge | director | 1077182 0.3285% | $2.51M | 8 | 2 | <0.0001% |
| RAKIN KEVIN | director | 245563 0.0749% | $572,161.79 | 2 | 1 | |
| Kompella Uday | director | 154416 0.0471% | $359,789.28 | 0 | 13 | |
| Castillo Kirsten | director | 75000 0.0229% | $174,750.00 | 2 | 3 | +1.63% |
| Subramanian Sanjay | Chief Financial Officer | 35591 0.0109% | $82,927.03 | 2 | 7 | <0.0001% |
| Potti Manish | director | 27695 0.0084% | $64,529.35 | 0 | 3 | |
| GILL DAVID N | director | 14000 0.0043% | $32,620.00 | 4 | 0 | +2.86% |
| Fernandes Prabhavathi | director | 10000 0.003% | $23,300.00 | 1 | 1 | +2.2% |
| Gridley Adam | President and CEO | 7000 0.0021% | $16,310.00 | 2 | 0 | <0.0001% |
| Lieber Jonathan I | Chief Financial Officer | 5000 0.0015% | $11,650.00 | 1 | 0 | <0.0001% |
| Kumar Ramesh | director | 0 0% | $0 | 0 | 7 | |
| Tammara Vijay | Senior Vice President | 0 0% | $0 | 0 | 3 |
$831,902,292 | 108 | 9.34% | $853.44M | |
$860,541,348 | 82 | -5.10% | $682.13M | |
$96,660,103 | 38 | -2.10% | $850.19M | |
$41,446,394 | 27 | 12.91% | $748.13M | |
$7,598,498 | 27 | 34.68% | $655.18M | |
$47,612,919 | 22 | -30.91% | $688.48M | |
$49,975,021 | 20 | 40.90% | $822.66M | |
Ocugen, Inc. (OCGN) | $2,516,932 | 19 | -15.78% | $764M |
$46,858,891 | 18 | -11.58% | $626.03M | |
$59,102,045 | 17 | 8.52% | $684.08M | |
$26,254,270 | 14 | 24.18% | $705.87M | |
$133,809,976 | 13 | 31.29% | $788.67M | |
$140,543,039 | 10 | 0.77% | $618.97M | |
$11,541,901 | 10 | 8.07% | $771.12M | |
$175,670,559 | 10 | -7.31% | $844.34M | |
$1,229,070 | 10 | 23.53% | $789.83M | |
$38,624,786 | 9 | 1.26% | $828.84M | |
$94,000,000 | 7 | -20.84% | $662.63M | |
$13,900 | 1 | -39.25% | $838.53M |
| Increased Positions | 65 | +65.66% | 22M | +45.59% |
| Decreased Positions | 35 | -35.35% | 8M | -17.4% |
| New Positions | 33 | New | 6M | New |
| Sold Out Positions | 14 | Sold Out | 5M | Sold Out |
| Total Postitions | 129 | +30.3% | 61M | +28.19% |
| Vanguard Group Inc | $21,009.00 | 4.88% | 15.22M | +450,904 | +3.05% | 2025-09-30 |
| Millennium Management Llc | $5,744.00 | 1.33% | 4.16M | -896,777 | -17.73% | 2025-09-30 |
| Gmt Capital Corp | $5,732.00 | 1.33% | 4.15M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $5,595.00 | 1.3% | 4.05M | -2M | -27.48% | 2025-09-30 |
| Geode Capital Management, Llc | $5,075.00 | 1.18% | 3.68M | +189,391 | +5.43% | 2025-09-30 |
| Citadel Advisors Llc | $2,164.00 | 0.5% | 1.57M | +966,197 | +160.49% | 2025-09-30 |
| State Street Corp | $1,870.00 | 0.43% | 1.36M | +16,458 | +1.23% | 2025-09-30 |
| Rinkey Investments | $1,535.00 | 0.36% | 1.11M | -66,332 | -5.63% | 2025-09-30 |
| Gsa Capital Partners Llp | $1,437.00 | 0.33% | 1.04M | -686,963 | -39.74% | 2025-09-30 |
| Ubs Group Ag | $1,414.00 | 0.33% | 1.02M | +370,500 | +56.62% | 2025-09-30 |